Cardlytics Inc

CDLX

Market Cap$672.99M

Close$

Compare Cardlytics

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Cardlytics Inc	-5	0%	-100%	2.3	1.9
Market Avg	58.2	1.29%	31%	-	1
Consumer Discretionary Avg	27.4	0.67%	75%	3.2	1.3

$17.00

Target Price by Analysts

21.7% upsideCardlytics Target Price Details

$20.92

Current Fair Value

49.8% upside

Undervalued by 49.8% based on the discounted cash flow analysis.

Share Statistics

Market cap	$672.99 Million
Enterprise Value	$838.73 Million
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-3.69
Beta	3.03
Outstanding Shares	48,173,734
Avg 30 Day Volume	908,379

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-5.0
PEG	6.81
Price to Sales	2.33
Price to Book Ratio	6.99
Enterprise Value to Revenue	2.71
Enterprise Value to EBIT	-13.17
Enterprise Value to Net Income	-7
Total Debt to Enterprise	0.31
Debt to Equity	1.91

Revenue Sources

No data

ESG Score

No data

About Cardlytics Inc

CEO: Lynne Laube